Akanda AKAN
NASDAQ AKAN
$3.89 -0.17 (-4.19%)
As of: Aug 20, 2026 · 3:59 PM EDT

Akanda (AKAN) Short term Debt (2020 - 2025)

Akanda (AKAN) posted quarterly Short term Debt of $1.0 million for Q4 2025, up 185.4% year-over-year from $352814.0 in Q4 2024, and up 446.39% quarter-over-quarter from $184285.0 in Q2 2025.

Akanda (AKAN) Short term Debt (2020 - 2025) Analysis & Trends

Akanda's Short term Debt history runs 5 years deep, the most recent figure standing at $1.0 million for Q4 2025.

  • In Q4 2025, Short term Debt rose 185.4% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (up 185.4% YoY), while the FY2025 annual figure was $1.0 million, up 185.4% from the prior year.
  • Short term Debt for Q4 2025 stood at $1.0 million, up from $184285.0 in the prior quarter.
  • The five-year high for Short term Debt was $2.6 million in Q2 2022, with the low at $184285.0 in Q2 2025.
  • The 4-year median for Short term Debt is $905904.5 (2022), against an average of $1.1 million.
  • The sharpest annual moves came in 2024 and 2025: Short term Debt sank 85.69% in 2024, then jumped 185.4% in 2025.
  • Akanda's Short term Debt stood at $936793.0 in 2022, then fell by 6.59% to $875016.0 in 2023, then tumbled by 59.68% to $352814.0 in 2024, then jumped by 185.4% to $1.0 million in 2025.
  • Business Quant data shows AKAN's Short term Debt at $1.0 million in Q4 2025, $184285.0 in Q2 2025, and $352814.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Akanda 266,801.66 266,801.66 -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.01 Mn
Jun 30, 2025 184,285.00
Dec 31, 2024 352,814.00
Jun 30, 2024 354,586.00
Dec 31, 2023 875,016.00
Jun 30, 2023 2.48 Mn
Dec 31, 2022 936,793.00
Jun 30, 2022 2.57 Mn
Dec 31, 2020 2.26 Mn